View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Comment
June 1, 2022updated 27 Jul 2022 11:57am

Aidoc and Gleamer’s new partnership expands the use of AI in healthcare systems

The market for artificial intelligence (AI) and machine learning (ML) platforms will reach $52bn in 2024, up from $29bn in 2019.

By GlobalData Healthcare

The Covid-19 pandemic has had an unprecedented effect on healthcare institutions by overwhelming hospitals and exacerbating the shortage of healthcare professionals. While the healthcare industry has a reputation for being conservative and slow to adopt new technologies, in the upcoming years, artificial intelligence (AI) and machine learning (ML) are expected to further integrate into the healthcare industry due to the impact of the Covid-19 pandemic.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

Numerous healthcare companies are already implementing high-tech solutions into existing healthcare systems. One of the leading providers of healthcare AI solutions, Aidoc, has announced an agreement with French medtech company Gleamer to integrate Gleamer’s AI BoneView solution for X-rays.

According to GlobalData analysis and forecasts, AI and ML are two of the fastest-growing technologies in the healthcare industry; the market for AI/ML platforms will reach $52bn in 2024, up from $29bn in 2019. AI technologies are able to provide assistance and automate image analysis. The use of AI technologies in image processing reduces error rate, thus improving patient outcomes. In addition, Aidoc’s AI platform can integrate and organise various AI solutions from third-party vendors into an entire network of facilities.

With X-ray accounting for one of the highest percentages of hospital imaging volumes, as well as a lack of healthcare specialists in US hospitals following the Covid-19 pandemic, the BoneView solution will reduce the time needed to analyse X-rays and alleviate the burden on healthcare personnel.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network